24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Michael Levitt
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:14
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
19:40
Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems
19:09
Intel VP: “We’re just not going to accept subpar products”
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
3
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
4
Check Point raises $1.75 billion, potentially eyeing AI expansion
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
Michael Levitt
3 stories about Michael Levitt
Take it or Levitt: A Nobel Prize winner’s winding road to the top
09.02.25
|
Roni Dori
Prof. Michael Levitt talks about his unconventional life path, from childhood in South Africa with a single mother, emigrating to England, and finding logic in the chaos of nature.
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
13.03.20
|
Ari Libsker
Nobel laureate and Stanford professor of Biology assures Israelis: statistics show the virus is on a downturn. Read more!
Paving the Way to Alzheimer’s Cure, One Algorithm at a Time
19.07.19
|
Tzipi Smilovitz
Israeli scientist Shahar Barbash is making waves in the pharmaceutical world with a new approach to image analysis that has even chemistry Nobel laureate Michael Levitt on board